TEAM{理監事團隊}

學歷

• 國立陽明大學醫學系畢業

經歷

1. 馬偕兒童醫院兒童血液腫瘤科資深主治醫師
2. 馬偕醫學院醫學系兼任講師
3. 台灣兒童癌症研究群(Taiwan Pediatric Oncology Group) 肝腫瘤治療計畫主持人
4. 馬偕紀念醫院小兒科住院醫師、總醫師
5. 馬偕紀念醫院小兒血液腫瘤科臨床研究員
6. 馬偕紀念醫院兒童急救加護醫學科主治醫師
7. 馬偕醫護管理專科學校兼任講師
8. St. Jude Children’s Research Hospital骨髓移植/細胞治療/加護病房進修
9. Cincinnati Children’s Hospital Medical Center 肝腫瘤進修
10. 中華民國兒童癌症基金會顧問醫師
11. 國際小兒腫瘤學會(International Society of Paediatric Oncology)會員
12. 歐洲血友病及相關疾病協會(European Association for Haemophilia and Allied Disorders)會員

專長領域

1. 兒童血液腫瘤疾病
2. 兒童肝臟腫瘤
3. 兒童白血病
4. 凝血功能
5. 血小板疾患

專業著作

• (2021~2024)
• Hou JY, Yeh TC, Huang TH, Sheu JC, Liu HC. A retrospective study of clinical features and outcome in patients with refractory or recurrent hepatoblastoma: A single institution experience. PediatrNeonatol. 2021 Apr 27;S1875-9572(21)00061-9. doi: 10.1016/j.pedneo.2021.03.018.
• Ho WL, Hung GY, Yen HJ, Yang YL, Chang HH, Lu MY, Lin KH, Chen JS, Cheng CN, Hung IJ, Yang CP, Chen SH, Liu HC, Yeh TC, Hou JY, et al. Characteristics and outcomes of second cancers in patients with childhood cancer: A report from the Taiwan Pediatric Oncology Group.J Formos Med Assoc. 2022 Jan;121(1 Pt 2):350-359. doi: 10.1016/j.jfma.2021.05.012. Epub 2021 Jun 18.
• Andrés-Jensen L, Attarbaschi A, Bardi E, Barzilai-Birenboim S, Bhojwani D, Hagleitner MM, Halsey C, Harila-Saari A, van Litsenburg RRL, Hudson MM, Jeha S, Kato M, Kremer L, Mlynarski W, Möricke A, Pieters R, Piette C, Raetz E, Ronceray L, Toro C, Grazia Valsecchi M, Vrooman LM, Weinreb S, Winick N, Schmiegelow K; Ponte di Legno Severe Toxicity Working Group. (Ponte di Legno Severe Toxicity Working Group: Andishe Attarbaschi, Madeline R Adams, Liv Andres-Jensen, Edit Bardi, Shlomit Barzilai-Birenboim, Katja Baust, Deepa Bhojwani, Tineke Boesten, Gabriele Calaminus, Rachel Conyers, Anne-Sophie Darlington, Maëlle de Ville, Gabriele Escherich, Melanie Hagleitner, Christina Halsey, Arja Harila-Saari, Jen-Yin Hou, et al. Severe toxicity free survival: physician-derived definitions of unacceptable long-term toxicities following acute lymphocytic leukaemia. Lancet Haematol. 2021 Jul;8(7):e513-e523. doi: 10.1016/S2352-3026(21)00136-8.
• Yeh TC, Hou JY, Huang TH, Lu CH, Sun FJ, Huang HM, Liu HC. Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia. Sci Rep. 2021 Oct 27;11(1):21142. doi: 10.1038/s41598-021-00725-5.
• Singkham N, Punyawudho B, Yu MS, Cheng SN, Chen SH, Chang H, Chen CC, Hsiao CC, Hou JY, et al.Influence of blood group and von Willebrand factor on population pharmacokinetics and dose individualization of recombinant factor VIII in Taiwanese patients with haemophilia A. Haemophilia. 2022 Mar;28(2):230-238. doi: 10.1111/hae.14493. Epub 2022 Jan 20.
• Wang CH, Cheng KH, Hou JY.Sonographic diagnosis of intramural duodenal hematoma.PediatrNeonatol. 2022 Aug 11:S1875-9572(22)00176-0. doi: 10.1016/j.pedneo.2022.07.003.
• Huang TH, Hung GY, Weng TF, Wang FM, Lee CY, Lin DT, Chen BW, Lin KH, Wu KH, Liu HC, Chen JS, Jou ST, Hou JY,et al. Surgical treatment confers prognostic significance in pediatric malignant mediastinal germ cell tumors.Cancer. 2022 Dec 1;128(23):4139-4149. doi: 10.1002/cncr.34494.
• Liu YC, Yeh TC, Wu PS, Sheu JC, Lee HC, Yeung CY, Jiang CB, Liu HC, Hou JY, Chan WT. Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.Medicine (Baltimore). 2022 Nov 25;101(47):e31752. doi: 10.1097/MD.0000000000031752.
• Liang ML, Yeh TC, Huang MH, Wu PS, Wu SP, Huang CC, Yen TY, Ting WH, Hou JY, et al. Application of Drug Testing Platforms in Circulating Tumor Cells and Validation of a Patient-Derived Xenograft Mouse Model in Patient with Primary Intracranial Ependymomas with Extraneural Metastases. Diagnostics (Basel). 2023 Mar 24;13(7):1232. doi: 10.3390/diagnostics13071232.
• Lew CZ, Liu HC, Hou JY, Huang TH, Yeh TC. Pediatric Extracranial Germ Cell Tumors: Review of Clinics and Perspectives in Application of Autologous Stem Cell Transplantation. Cancers (Basel). 2023 Mar 27;15(7):1998. doi: 10.3390/cancers15071998.
• Lin YC, Liu HC, Hou JY, Shih BF, Yeh TC. Pediatric Cardiac Lymphoblastic Lymphoma: A Case Report and Review of the Literature. J PediatrHematol Oncol. 2023 Jul 1;45(5):281-284. doi: 10.1097/MPH.0000000000002676. Epub 2023 Apr 17.
• Hou JY, Hsieh PY, Lei R, Chen CM, Cheng M, Chen YC. A Prospective, Observational, Multi-Center Study of Rurioctocog Alfa Pegol Pharmacokinetic-Guided Prophylaxis Using Mypkfit in Severe Hemophilia a Patients in Taiwan (ATTRACT-HA Study): An Interim Analysis. Blood (2023) 142 (Supplement 1): 5484.
• Liu HC, Huang YJ, Jaing TH, Wu KH, Chen SH, Wang SC, Yeh TC, Hsiao CC, Chang TK, Yen HJ, Huang FL, Lin PC,Hou JY, et al. Refining risk stratification in paediatric B-acute lymphoblastic leukaemia: Combining IKZF1plus and Day 15 MRD positivity. Br J Haematol. 2024 Apr;204(4):1344-1353. doi: 10.1111/bjh.19338. Epub 2024 Mar 13.
• Lu YA, Liu HC,Hou JY, Chiu NC, Huang TH, Yeh TC. The clinical impact of primary granulocyte-colony stimulating factor prophylaxis in children with acute lymphoblastic leukemia who underwent induction chemotherapy. J MicrobiolImmunol Infect. 2024 Aug 20:S1684-1182(24)00148-8. doi: 10.1016/j.jmii.2024.08.004.